Heron Therapeuti Stock Buy Hold or Sell Recommendation
| HRTX Stock | USD 2.32 0.09 3.73% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Heron Therapeuti is 'Strong Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Heron Therapeuti given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Heron Therapeuti, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Heron Therapeuti Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide. In addition, we conduct extensive research on individual companies such as Heron and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Heron Therapeuti. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Heron |
Execute Heron Therapeuti Buy or Sell Advice
The Heron recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Heron Therapeuti. Macroaxis does not own or have any residual interests in Heron Therapeuti or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Heron Therapeuti's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | OK | Details | |
Volatility | Very risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Heron Therapeuti Trading Alerts and Improvement Suggestions
| Heron Therapeuti is way too risky over 90 days horizon | |
| Heron Therapeuti appears to be risky and price may revert if volatility continues | |
| Heron Therapeuti has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 144.28 M. Net Loss for the year was (13.58 M) with profit before overhead, payroll, taxes, and interest of 88.95 M. | |
| Heron Therapeuti currently holds about 83.54 M in cash with (22.53 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.81. | |
| Over 77.0% of the company shares are owned by institutional investors | |
| Latest headline from gurufocus.com: TANG KEVIN Cs Strategic Acquisition of Aurinia Pharmaceuticals Shares |
Heron Therapeuti Returns Distribution Density
The distribution of Heron Therapeuti's historical returns is an attempt to chart the uncertainty of Heron Therapeuti's future price movements. The chart of the probability distribution of Heron Therapeuti daily returns describes the distribution of returns around its average expected value. We use Heron Therapeuti price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Heron Therapeuti returns is essential to provide solid investment advice for Heron Therapeuti.
| Mean Return | 0.60 | Value At Risk | -5.88 | Potential Upside | 8.02 | Standard Deviation | 5.59 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Heron Therapeuti historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Heron Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Heron Therapeuti, soars without any apparent reason? This usually happens because many institutional investors are aggressively trading Heron Therapeuti back and forth among themselves.
| Shares | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 2.8 M | Congress Park Capital Llc | 2024-12-31 | 2.5 M | Jw Asset Management, Llc | 2024-12-31 | 2.3 M | Tang Capital Management Llc | 2024-12-31 | 2.1 M | Orchard Capital Management, Llc | 2024-12-31 | 1.9 M | Clearline Capital Lp | 2024-12-31 | 1.8 M | New York State Common Retirement Fund | 2024-12-31 | 1.3 M | Monaco Asset Management | 2024-12-31 | 1.2 M | Renaissance Technologies Corp | 2024-12-31 | 1.2 M | Rubric Capital Management Lp | 2024-12-31 | 26.7 M | Blackrock Inc | 2024-12-31 | 8.6 M |
Heron Therapeuti Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (16.9M) | (6.5M) | (6.2M) | 12.5M | (11.1M) | (10.5M) | |
| Change In Cash | 33.2M | (14.6M) | (75.2M) | 13.3M | (2.9M) | (2.7M) | |
| Free Cash Flow | (191.6M) | (206.4M) | (148.7M) | (60.3M) | (24.2M) | (25.4M) | |
| Depreciation | 2.8M | 3.0M | 2.9M | 2.9M | 2.5M | 2.6M | |
| Other Non Cash Items | 1.4M | 904K | (251K) | (773K) | 3.2M | 3.4M | |
| Capital Expenditures | 6.8M | 3.0M | 1.8M | 1.5M | 1.7M | 1.8M | |
| Net Income | (227.3M) | (220.7M) | (182.0M) | (110.6M) | (13.6M) | (14.3M) | |
| End Period Cash Flow | 105.1M | 90.5M | 15.4M | 28.7M | 25.8M | 28.5M | |
| Change Receivables | (22.8M) | 24.8M | (2.0M) | 6.4M | 7.3M | 7.7M | |
| Change To Netincome | 51.6M | 51.1M | 48.5M | 42.5M | 48.9M | 29.2M | |
| Investments | 215.8M | 35.7M | (3.3M) | 28.9M | 18.7M | 19.6M |
Heron Therapeuti Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Heron Therapeuti or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Heron Therapeuti's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Heron stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.76 | |
β | Beta against Dow Jones | 1.19 | |
σ | Overall volatility | 5.61 | |
Ir | Information ratio | 0.13 |
Heron Therapeuti Volatility Alert
Heron Therapeuti shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Heron Therapeuti's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Heron Therapeuti's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Heron Therapeuti Fundamentals Vs Peers
Comparing Heron Therapeuti's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Heron Therapeuti's direct or indirect competition across all of the common fundamentals between Heron Therapeuti and the related equities. This way, we can detect undervalued stocks with similar characteristics as Heron Therapeuti or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Heron Therapeuti's fundamental indicators could also be used in its relative valuation, which is a method of valuing Heron Therapeuti by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Heron Therapeuti to competition |
| Fundamentals | Heron Therapeuti | Peer Average |
| Return On Equity | -24.09 | -0.31 |
| Return On Asset | -0.0316 | -0.14 |
| Profit Margin | (0.09) % | (1.27) % |
| Operating Margin | 0.10 % | (5.51) % |
| Current Valuation | 471.88 M | 16.62 B |
| Shares Outstanding | 152.33 M | 571.82 M |
| Shares Owned By Insiders | 0.77 % | 10.09 % |
| Shares Owned By Institutions | 76.80 % | 39.21 % |
| Number Of Shares Shorted | 30.77 M | 4.71 M |
| Price To Earning | (5.15) X | 28.72 X |
| Price To Book | 12.60 X | 9.51 X |
| Price To Sales | 2.45 X | 11.42 X |
| Revenue | 144.28 M | 9.43 B |
| Gross Profit | 88.95 M | 27.38 B |
| EBITDA | (5.06 M) | 3.9 B |
| Net Income | (13.58 M) | 570.98 M |
| Cash And Equivalents | 83.54 M | 2.7 B |
| Cash Per Share | 0.81 X | 5.01 X |
| Total Debt | 177.76 M | 5.32 B |
| Debt To Equity | 6.64 % | 48.70 % |
| Current Ratio | 1.77 X | 2.16 X |
| Book Value Per Share | (0.22) X | 1.93 K |
| Cash Flow From Operations | (22.53 M) | 971.22 M |
| Short Ratio | 15.90 X | 4.00 X |
| Earnings Per Share | (0.09) X | 3.12 X |
| Price To Earnings To Growth | (0.18) X | 4.89 X |
| Target Price | 6.0 | |
| Number Of Employees | 122 | 18.84 K |
| Beta | 1.55 | -0.15 |
| Market Capitalization | 353.41 M | 19.03 B |
| Total Asset | 233.15 M | 29.47 B |
| Retained Earnings | (1.92 B) | 9.33 B |
| Working Capital | 117.56 M | 1.48 B |
Note: Acquisition by Morgan Adam of 17950 shares of Heron Therapeuti subject to Rule 16b-3 [view details]
Heron Therapeuti Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Heron . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Heron Therapeuti Buy or Sell Advice
When is the right time to buy or sell Heron Therapeuti? Buying financial instruments such as Heron Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Heron Therapeuti in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Food Products Thematic Idea Now
Food Products
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Food Products theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Food Products Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Heron Stock Analysis
When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.